These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 10751238

  • 21. Long term (4 years) improved insulin sensitivity following islet cell transplant in type 1 diabetes.
    Rydzon B, Monson RS, Oberholzer J, Varady KA, Bellin MD, Danielson KK.
    Diabetes Metab Res Rev; 2018 Mar; 34(3):. PubMed ID: 29230944
    [Abstract] [Full Text] [Related]

  • 22. Beta-cell function evaluated by HOMA as a predictor of secondary sulphonylurea failure in Type 2 diabetes.
    Taverna MJ, Pacher N, Bruzzo F, Slama G, Selam JL.
    Diabet Med; 2001 Jul; 18(7):584-8. PubMed ID: 11553190
    [Abstract] [Full Text] [Related]

  • 23. Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial.
    Lund SS, Tarnow L, Stehouwer CD, Schalkwijk CG, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag A.
    Diabetes Obes Metab; 2007 May; 9(3):394-407. PubMed ID: 17391168
    [Abstract] [Full Text] [Related]

  • 24. Determinants for inadequate glycaemic control in Chinese patients with mild-to-moderate type 2 diabetes on oral antidiabetic drugs alone.
    Zhang SL, Chen ZC, Yan L, Chen LH, Cheng H, Ji LN.
    Chin Med J (Engl); 2011 Aug; 124(16):2461-8. PubMed ID: 21933588
    [Abstract] [Full Text] [Related]

  • 25. Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin.
    Rosenfalck AM, Thorsby P, Kjems L, Birkeland K, Dejgaard A, Hanssen KF, Madsbad S.
    Acta Diabetol; 2000 Mar; 37(1):41-6. PubMed ID: 10928235
    [Abstract] [Full Text] [Related]

  • 26. The relationship between vitronectin and hepatic insulin resistance in type 2 diabetes mellitus.
    Cao Y, Li X, Lu C, Zhan X.
    Endocr J; 2018 Jul 28; 65(7):747-753. PubMed ID: 29780059
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.
    Levy JC, Rudenski A, Burnett M, Knight R, Matthews DR, Turner RC.
    Diabetologia; 1991 Jul 28; 34(7):488-99. PubMed ID: 1916054
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effects of one year treatment of sibutramine on insulin resistance parameters in type 2 diabetic patients.
    Derosa G, Maffioli P, Ferrari I, Palumbo I, Randazzo S, D'Angelo A, Cicero AF.
    J Pharm Pharm Sci; 2010 Jul 28; 13(3):378-90. PubMed ID: 21092710
    [Abstract] [Full Text] [Related]

  • 36. Predictive clinical parameters for therapeutic efficacy of rosiglitazone in Korean type 2 diabetes mellitus.
    Kim YM, Cha BS, Kim DJ, Choi SH, Kim SK, Ahn CW, Lim SK, Kim KR, Huh KB, Lee HC.
    Diabetes Res Clin Pract; 2005 Jan 28; 67(1):43-52. PubMed ID: 15620433
    [Abstract] [Full Text] [Related]

  • 37. Twice daily insulin therapy in patients with type 2 diabetes and secondary failure to sulphonylureas.
    Wolffenbuttel BH, Weber RF, Weeks L, van Koetsveld PM, Verschoor L.
    Diabetes Res; 1990 Feb 28; 13(2):79-84. PubMed ID: 2091874
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.